EDIT Stock Summary and Trading Ideas (Editas Medicine | NASDAQ:EDIT)

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Editas Medicine trades on the NASDAQ stock market under the symbol EDIT.

As of September 16, 2026, EDIT stock price climbed to $2.71 with 2,354,608 million shares trading.

EDIT has a beta of 2.84, meaning it tends to be more sensitive to market movements. EDIT has a correlation of 0.17 to the broad based SPY ETF.

EDIT has a market cap of $415.88 million. This is considered a Small Cap stock.

Last quarter Editas Medicine reported $12 million in Revenue and -$.15 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.13.

In the last 3 years, EDIT traded as high as $11.69 and as low as $.91.

The top ETF exchange traded funds that EDIT belongs to (by Net Assets): VTI, VXF, VTWO, VHT, SCHA.

EDIT has underperformed the market in the last year with a price return of +1.5% while the SPY ETF gained +15.2%. However, in the short term, EDIT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.2% vs +0.1% return in SPY. But in the last 2 weeks, EDIT shares have been beat by the market, returning -11.7% compared to an SPY return of -1.0%.

EDIT support price is $2.49 and resistance is $2.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EDIT shares will trade within this expected range on the day.